Silence Therapeutics plc (SLN)
NASDAQ·Healthcare·Biotechnology
$7.71
-1.41%
Mkt Cap $292.38M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $2.91M | $39.00K | -98.66% | -$0.32 | -$0.25 | +21.88% | — | — |
| Q4 2025 Nov 6, 2025 | $3.10M | $159.00K | -94.88% | -$0.40 | -$0.45 | -12.50% | — | — |
| Q3 2025 Aug 7, 2025 | $3.25M | $224.00K | -93.11% | -$0.27 | -$0.54 | -100.00% | — | — |
| Q2 2025 May 8, 2025 | $2.32M | $142.00K | -93.88% | -$0.18 | -$0.60 | -233.33% | — | — |
| Q1 2025 Feb 27, 2025 | $6.77M | $24.33M | +259.38% | -$0.45 | $0.27 | +160.00% | — | — |
| Q4 2024 Nov 14, 2024 | $5.69M | $1.14M | -79.94% | -$0.42 | -$0.75 | -78.57% | — | — |
| Q2 2024 May 16, 2024 | $6.32M | $15.70M | +148.46% | -$0.23 | -$0.05 | +78.26% | — | — |
| Q4 2023 Nov 14, 2023 | $2.92M | $2.80M | -4.02% | -$0.56 | -$0.28 | +50.00% | — | — |
| Q3 2023 Aug 16, 2023 | $3.81M | $9.10M | +138.91% | -$0.59 | -$0.36 | +38.98% | — | — |
| Q2 2023 May 16, 2023 | $3.14M | $11.37M | +261.97% | -$0.51 | -$0.35 | +31.37% | — | — |
| Q4 2022 Nov 10, 2022 | — | $3.37M | — | -$0.60 | -$0.25 | +58.33% | — | — |
| Q3 2022 Aug 11, 2022 | — | $3.64M | — | -$0.60 | -$1.20 | -99.45% | — | — |
| Q2 2022 May 16, 2022 | — | $5.72M | — | -$0.62 | -$0.77 | -24.23% | — | — |
| Q1 2022 Mar 17, 2022 | $9.09M | $3.41M | -62.43% | -$0.62 | -$0.42 | +32.26% | — | — |
| Q2 2021 Jun 30, 2021 | — | $2.70M | — | — | -$0.39 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $3.14M | — | — | -$0.29 | — | — | — |
| Q1 2021 Mar 30, 2021 | — | $2.35M | — | — | -$0.43 | — | — | — |
| Q3 2020 Sep 30, 2020 | — | $1.99M | — | — | -$0.33 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | $573.00K | — | — | -$0.21 | — | — | — |
| Q1 2020 Mar 31, 2020 | — | $573.00K | — | — | -$0.21 | — | — | — |